Mark Milner, MD
Ophthalmology · Palm Beach Gardens, FLNPI 1932171147
Payments from drug & device makers
Across 1,360 payments — averaging $895.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$295K
- Bausch & Lomb Americas Inc.$188K
- Tarsus Pharmaceuticals, Inc.$145K
- Sun Pharmaceutical Industries Inc.$114K
- Eyevance Pharmaceuticals LLC$110K
- Oyster Point Pharma, Inc.$105K
- plus $259K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 332 | $295,101 |
| Bausch & Lomb Americas Inc. | 167 | $187,873 |
| Tarsus Pharmaceuticals, Inc. | 84 | $145,469 |
| Sun Pharmaceutical Industries Inc. | 144 | $114,142 |
| Eyevance Pharmaceuticals LLC | 98 | $109,979 |
| Oyster Point Pharma, Inc. | 109 | $105,497 |
| Biotissue Holdings Inc. | 57 | $98,192 |
| Alcon | 59 | $63,321 |
| Dompe US, Inc. | 49 | $38,106 |
| Novartis | 56 | $15,619 |
| Shire North American Group Inc | 22 | $15,104 |
| Alcon Research LLC | 5 | $13,000 |
| Thea Pharma Inc. | 3 | $7,403 |
| Tearlab Corp | 7 | $2,169 |
| Mallinckrodt Hospital Products Inc. | 56 | $1,510 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $1,370 |
| Glaukos Corporation | 27 | $1,051 |
| Harrow Eye, LLC | 18 | $788 |
| Johnson & Johnson Surgical Vision, Inc. | 12 | $597 |
| Rayner Intraocular Lenses Limited | 11 | $319 |
| ANI Pharmaceuticals, Inc. | 8 | $173 |
| Kala Pharmaceuticals, Inc. | 8 | $163 |
| Sight Sciences, Inc. | 3 | $162 |
| Amgen(2 entities) | 4 | $80 |
| NEW World Medical,inc. | 3 | $77 |
| Rxsight Inc | 3 | $60 |
| Ocular Therapeutix, Inc. | 2 | $42 |
| Aerie Pharmaceuticals, Inc. | 2 | $32 |
| Mallinckrodt Enterprises LLC | 1 | $26 |
| Omeros Corporation | 1 | $19 |
| Apellis Pharmaceuticals, Inc. | 1 | $19 |
How this compares
$1,217,463 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Palm Beach Gardens
- Jorge FortunPalm Beach Gardens$940K
- David EichenbaumSt Petersburg$34.4M
- Robert RadenDelray Beach$7.8M
- Carl DanzigPompano Beach$5.3M
- Bruce SegalDelray Beach$4.7M
- Cathleen McCabeBradenton$4.6M
- Ivan SunerTampa$3.7M
- Sunir JoshiFt Lauderdale$3.7M
- Harold BrooksTallahassee$3.5M
- Matthew CunninghamOrlando$2.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.